Literature DB >> 24835771

Protein expression of hypoxia-inducible factor-1 alpha and hepatocellular carcinoma: a systematic review with meta-analysis.

Shiyi Cao1, Shengli Yang2, Chao Wu2, Yunxia Wang1, Jianxin Jiang3, Zuxun Lu4.   

Abstract

PURPOSE: To investigate the relationship of protein expression of hypoxia-inducible factor-1 alpha (HIF-1α) with clinicopathological factors and prognosis of hepatocellular carcinoma (HCC).
METHODS: PubMed and Embase were searched from their inception through August 2013 for studies that reported the association between protein expression of HIF-1α and HCC. Random effects meta-analyses were used to summarize the odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: Eight studies involving 851 patients with HCC were included. Protein expression level of HIF-1α was not found to be related with capsule formation, cirrhosis, tumor size, and tumor differentiation of HCC, except vascular invasion. The positive association between HIF-1α expression and vascular invasion of HCC was statistically significant (OR: 2.04, 95% CI: 1.31-3.18). As a prognostic factor, a high level of HIF-1α expression would be associated with a poor disease-free survival (OR: 2.10, 95% CI: 1.48-2.97).
CONCLUSION: Higher level of HIF-1α expression may indicate a bigger possibility of vascular invasion and a poorer prognosis of HCC.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24835771     DOI: 10.1016/j.clinre.2014.04.004

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN: 2210-7401            Impact factor:   2.947


  18 in total

1.  Hepatic Artery Embolization Induces the Local Overexpression of Transforming Growth Factor β1 in a Rat Hepatoma Model.

Authors:  Eisuke Ueshima; Hideyuki Nishiofuku; Haruyuki Takaki; Yutaka Hirata; Hiroshi Kodama; Toshihiro Tanaka; Kimihiko Kichikawa; Koichiro Yamakado; Takuya Okada; Keitaro Sofue; Masato Yamaguchi; Koji Sugimoto; Takamichi Murakami
Journal:  Liver Cancer       Date:  2019-10-16       Impact factor: 11.740

2.  Distinguished prognosis after hepatectomy of HBV-related hepatocellular carcinoma with or without cirrhosis: a long-term follow-up analysis.

Authors:  Sheng-Li Yang; Li-Ping Liu; Yun-Fan Sun; Xing-Rong Yang; Jia Fan; Jian-Wei Ren; George G Chen; Paul B S Lai
Journal:  J Gastroenterol       Date:  2015-11-25       Impact factor: 7.527

3.  Expression of hypoxia-inducible factor 3α in hepatocellular carcinoma and its association with other hypoxia-inducible factors.

Authors:  Ping Liu; Xiefan Fang; Yang Song; Jian-Xin Jiang; Qian-Jin He; Xiang-Jie Liu
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

Review 4.  Clinicopathological and prognostic significance of hypoxia-inducible factor-1 alpha in lung cancer: a systematic review with meta-analysis.

Authors:  Sheng-Li Yang; Quan-Guang Ren; Lu Wen; Jian-Li Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

5.  Prognostic role of hypoxia-inducible factor-1 alpha expression in osteosarcoma: a meta-analysis.

Authors:  Hai-Yong Ren; Yin-Hua Zhang; Heng-Yuan Li; Tao Xie; Ling-Ling Sun; Ting Zhu; Sheng-Dong Wang; Zhao-Ming Ye
Journal:  Onco Targets Ther       Date:  2016-03-14       Impact factor: 4.147

6.  Can insulin-like growth factor 1 (IGF-1), IGF-1 receptor connective tissue growth factor and Ki-67 labelling index have a prognostic role in pulmonary carcinoids?

Authors:  Georgios A Kanakis; Lars Grimelius; Dimitrios Papaioannou; Gregory Kaltsas; Apostolos V Tsolakis
Journal:  Oncotarget       Date:  2018-04-27

Review 7.  The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

Authors:  Dongjun Luo; Zhongxia Wang; Junyi Wu; Chunping Jiang; Junhua Wu
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

8.  Downregulation and pro-apoptotic effect of hypoxia-inducible factor 2 alpha in hepatocellular carcinoma.

Authors:  Sheng-Li Yang; Li-Ping Liu; Leilei Niu; Yun-Fan Sun; Xing-Rong Yang; Jia Fan; Jian-Wei Ren; George G Chen; Paul B S Lai
Journal:  Oncotarget       Date:  2016-06-07

9.  Bufalin suppresses hepatocellular carcinoma invasion and metastasis by targeting HIF-1α via the PI3K/AKT/mTOR pathway.

Authors:  Haiyong Wang; Chenyue Zhang; Litao Xu; Kun Zang; Zhouyu Ning; Feng Jiang; Huiying Chi; Xiaoyan Zhu; Zhiqiang Meng
Journal:  Oncotarget       Date:  2016-04-12

Review 10.  Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma.

Authors:  Olga Krivtsova; Anna Makarova; Natalia Lazarevich
Journal:  World J Hepatol       Date:  2018-10-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.